Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

 

Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019
Avatar

Mechanisms of Immune Activation and Inhibition in Glioblastoma: CPi and Enrichment Biomarkers

By Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019 FEATURING Amy Heimberger
By Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019 FEATURING Amy Heimberger
416 views
May 30, 2019
0 Comments
Login to view comments. Click here to Login
Updates in Oncology
15:43
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

Adjuvant TKI Therapy in Early Stage and Metastatic GIST: Which Patie…

Feat. G. Demetri
17:55
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

Current State of Knowledge and Unmet Needs in EGFRvIII and CMV Antig…

Feat. A. Heimberger
07:25
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

Managing Metastatic Non-GIST Soft Tissue Sarcomas: Combination Chemo…

Feat. G. Demetri
06:11
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

Histology-Specific Management of Non-GIST Soft Tissue Sarcomas: Pazo…

Feat. G. Demetri
12:23
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

Next Generation Sequencing and Molecular Targeted Therapies in Patie…

Feat. G. Demetri
32:33
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

Adjuvant Chemotherapy for HR+/HER2- Breast Cancer - How MINDACT, TAI…

Feat. L. Carey
11:57
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

HR+/HER2- Breast Cancer - Who Needs Extended Adjuvant Endocrine Ther…

Feat. L. Carey
22:56
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

Advanced Ovarian Cancer: Neoadjuvant Chemotherapy or Primary Surgery?

Feat. R. Coleman
08:13
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

Biologics in First-Line Ovarian Cancer Treatment: AAi, anti-VEGF, PA…

Feat. R. Coleman
16:23
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

Combination Therapeutic Strategies in Recurrent Ovarian Cancer: (Pla…

Feat. R. Coleman
10:13
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

Mechanisms of Immune Activation and Inhibition in Glioblastoma: CPi …

Feat. A. Heimberger
11:41
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

STAT 3 Small Molecule Inhibitor WP1066 - Immune Suppressive Mechanis…

Feat. A. Heimberger
10:23
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

Overview of Systemic Treatments in Bladder Cancer in 2019

Feat. S. Srinivas
15:46
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

Neoadjuvant and Adjuvant Therapy in Localized Bladder Cancer: IO vs.…

Feat. S. Srinivas
07:12
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

IO Therapy in Metastatic Urothelial Cancer (mUC)

Feat. S. Srinivas
10:25
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

Promising New Drugs in Advanced Urothelial Cancer: Antibody+CPi+PARPi

Feat. S. Srinivas
05:17
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

Is There a Role for Adjuvant Therapy in Localized Renal Cell Carcino…

Feat. J. Graham
09:45
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

Personalized Approach to Metastatic Renal Cell Carcinoma: Prognostic…

Feat. J. Graham
16:29
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

Personalized Approach to Metastatic Renal Cell Carcinoma: First-Line…

Feat. J. Graham
10:04
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

Second-Line Systemic Therapy in Metastatic Renal Cell Carcinoma and …

Feat. J. Graham
49:30
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

Optimizing Your Oncology Practice

Feat. E. Towle
46:03
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

Integrating Integrative Medicine Into Supportive Care: Are We Ready?

Feat. G. Lopez
44:31
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

Drug Pricing and Oncology Practice

Feat. V. Prasad